Literature DB >> 20463401

Mitochondrial iron metabolism and its role in neurodegeneration.

Maxx P Horowitz1, J Timothy Greenamyre.   

Abstract

In addition to their well-established role in providing the cell with ATP, mitochondria are the source of iron-sulfur clusters (ISCs) and heme - prosthetic groups that are utilized by proteins throughout the cell in various critical processes. The post-transcriptional system that mammalian cells use to regulate intracellular iron homeostasis depends, in part, upon the synthesis of ISCs in mitochondria. Thus, proper mitochondrial function is crucial to cellular iron homeostasis. Many neurodegenerative diseases are marked by mitochondrial impairment, brain iron accumulation, and oxidative stress - pathologies that are inter-related. This review discusses the physiological role that mitochondria play in cellular iron homeostasis and, in so doing, attempts to clarify how mitochondrial dysfunction may initiate and/or contribute to iron dysregulation in the context of neurodegenerative disease. We review what is currently known about the entry of iron into mitochondria, the ways in which iron is utilized therein, and how mitochondria are integrated into the system of iron homeostasis in mammalian cells. Lastly, we turn to recent advances in our understanding of iron dysregulation in two neurodegenerative diseases (Alzheimer's disease and Parkinson's disease), and discuss the use of iron chelation as a potential therapeutic approach to neurodegenerative disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20463401      PMCID: PMC3085540          DOI: 10.3233/JAD-2010-100354

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  114 in total

1.  Non-transferrin-bound iron reaches mitochondria by a chelator-inaccessible mechanism: biological and clinical implications.

Authors:  Maya Shvartsman; Raghavendra Kikkeri; Abraham Shanzer; Z Ioav Cabantchik
Journal:  Am J Physiol Cell Physiol       Date:  2007-08-01       Impact factor: 4.249

2.  Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease.

Authors:  L Reznichenko; T Amit; H Zheng; Y Avramovich-Tirosh; M B H Youdim; O Weinreb; S Mandel
Journal:  J Neurochem       Date:  2006-03-15       Impact factor: 5.372

Review 3.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

4.  An oxidative stress-mediated positive-feedback iron uptake loop in neuronal cells.

Authors:  Claudia Núñez-Millacura; Victoria Tapia; Patricia Muñoz; Ricardo B Maccioni; Marco T Núñez
Journal:  J Neurochem       Date:  2002-07       Impact factor: 5.372

5.  Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease.

Authors:  Deepinder Kaur; Subramanian Rajagopalan; Julie K Andersen
Journal:  Brain Res       Date:  2009-08-21       Impact factor: 3.252

Review 6.  Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis.

Authors:  Sandro Altamura; Martina U Muckenthaler
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 7.  Maturation of iron-sulfur proteins in eukaryotes: mechanisms, connected processes, and diseases.

Authors:  Roland Lill; Ulrich Mühlenhoff
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

8.  Role of rasagiline in treating Parkinson's disease: Effect on disease progression.

Authors:  Irene A Malaty; Hubert H Fernandez
Journal:  Ther Clin Risk Manag       Date:  2009-06-04       Impact factor: 2.423

Review 9.  The role of iron in mitochondrial function.

Authors:  Sonia Levi; Ermanna Rovida
Journal:  Biochim Biophys Acta       Date:  2008-10-07

Review 10.  Physiological and pathological aspects of Abeta in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelators.

Authors:  Yael Avramovich-Tirosh; Tamar Amit; Orit Bar-Am; Orly Weinreb; Moussa B H Youdim
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

View more
  64 in total

Review 1.  HIV-associated sensory neuropathy: risk factors and genetics.

Authors:  Peter R Kamerman; Antonia L Wadley; Catherine L Cherry
Journal:  Curr Pain Headache Rep       Date:  2012-06

Review 2.  Novel mitochondrial targets for neuroprotection.

Authors:  Miguel A Perez-Pinzon; R Anne Stetler; Gary Fiskum
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-28       Impact factor: 6.200

3.  Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.

Authors:  Shannon L Rhodes; Daniel D Buchanan; Ismaïl Ahmed; Kent D Taylor; Marie-Anne Loriot; Janet S Sinsheimer; Jeff M Bronstein; Alexis Elbaz; George D Mellick; Jerome I Rotter; Beate Ritz
Journal:  Neurobiol Dis       Date:  2013-10-08       Impact factor: 5.996

4.  Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders.

Authors:  Niels Bergsland; Eleonora Tavazzi; Ferdinand Schweser; Dejan Jakimovski; Jesper Hagemeier; Michael G Dwyer; Robert Zivadinov
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

5.  Changing iron content of the mouse brain during development.

Authors:  Gregory P Holmes-Hampton; Mrinmoy Chakrabarti; Allison L Cockrell; Sean P McCormick; Louise C Abbott; Lora S Lindahl; Paul A Lindahl
Journal:  Metallomics       Date:  2012-07-19       Impact factor: 4.526

Review 6.  The role of iron in brain ageing and neurodegenerative disorders.

Authors:  Roberta J Ward; Fabio A Zucca; Jeff H Duyn; Robert R Crichton; Luigi Zecca
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

7.  Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells.

Authors:  Yee-Ki Lee; Philip Wing-Lok Ho; Revital Schick; Yee-Man Lau; Wing-Hon Lai; Ting Zhou; Yanhua Li; Kwong-Man Ng; Shu-Leung Ho; Miguel Angel Esteban; Ofer Binah; Hung-Fat Tse; Chung-Wah Siu
Journal:  Pflugers Arch       Date:  2013-12-11       Impact factor: 3.657

Review 8.  Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

9.  In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions.

Authors:  S R Burstein; F Valsecchi; H Kawamata; M Bourens; R Zeng; A Zuberi; T A Milner; S M Cloonan; C Lutz; A Barrientos; G Manfredi
Journal:  Hum Mol Genet       Date:  2018-01-01       Impact factor: 6.150

Review 10.  Common defects of mitochondria and iron in neurodegeneration and diabetes (MIND): a paradigm worth exploring.

Authors:  Matthew Stroh; Russell H Swerdlow; Hao Zhu
Journal:  Biochem Pharmacol       Date:  2013-12-19       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.